02
Organisation
DATE
Singapore – September 5, 2024 – Anomaly Bio is thrilled to announce its selection as a recipient of the highly competitive WTFund grant, initiated by Indian entrepreneur and philanthropist Nikhil Kamath. This $25,000 non-dilutive grant underscores Anomaly Bio's innovative approach and potential in the entrepreneurial landscape.
WTFund, inspired by the Thiel Fellowship, is India's premier non-dilutive grant fund designed to support emerging entrepreneurs under the age of 25. The selection process is notably rigorous, with an acceptance rate of less than 1%, involving multiple assessment rounds to identify the most promising talents.
With approximately 1 million followers on YouTube, Kamath's podcast offers insightful discussions on entrepreneurship and innovation.
Anomaly Bio is a Singapore-based company that develops next-generation bio-based ingredients through advanced fermentation and strain engineering. We engineer metabolic pathways in microorganisms to convert readily available feedstocks such as sugars into high-value ingredients for crop protection, nutrition, and personal care. By transforming microbes into efficient cell factories, we replace fragile, extraction-based supply chains with scalable, on-demand, and globally viable biomanufacturing. Legacy ingredient companies were built on extraction, we’re building the future with synthetic biology and advanced fermentation.